| 000 | 01762 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517023107.0 | ||
| 264 | 0 | _c20170104 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1728-7731 | ||
| 024 | 7 |
_a10.1016/j.jcma.2015.02.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Sheng-Hsiang | |
| 245 | 0 | 0 |
_aRituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. _h[electronic resource] |
| 260 |
_bJournal of the Chinese Medical Association : JCMA _cJul 2015 |
||
| 300 |
_a400-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInduction Chemotherapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMediastinal Neoplasms _xmortality |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 700 | 1 | _aHsiao, Liang-Tsai | |
| 700 | 1 | _aChiou, Tzeon-Jye | |
| 700 | 1 | _aYang, Ching-Fen | |
| 700 | 1 | _aYu, Yuan-Bin | |
| 700 | 1 | _aLiu, Chun-Yu | |
| 700 | 1 | _aGau, Jyh-Pyng | |
| 700 | 1 | _aLiu, Jin-Hwang | |
| 700 | 1 | _aChen, Po-Min | |
| 700 | 1 | _aTzeng, Cheng-Hwai | |
| 773 | 0 |
_tJournal of the Chinese Medical Association : JCMA _gvol. 78 _gno. 7 _gp. 400-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcma.2015.02.005 _zAvailable from publisher's website |
| 999 |
_c24734937 _d24734937 |
||